Abstract:Efficient delivery of therapeutics across the neuroprotective blood-brain barrier (BBB) remains a formidable challenge for central nervous system drug development. High-fidelity in vitro models of the BBB could facilitate effective early screening of drug candidates targeting the brain. In this study, we developed a microfluidic BBB model that is capable of mimicking in vivo BBB characteristics for a prolonged period and allows for reliable in vitro drug permeability studies under recirculating perfusion. We derived brain microvascular endothelial cells (BMECs) from human induced pluripotent stem cells (hiPSCs) and cocultured them with rat primary astrocytes on the two sides of a porous membrane on a pumpless microfluidic platform for up to 10 days. The microfluidic system was designed based on the blood residence time in human brain tissues, allowing for medium recirculation at physiologically relevant perfusion rates with no pumps or external tubing, meanwhile minimizing wall shear stress to test whether shear stress is required for in vivo-like barrier properties in a microfluidic BBB model. This BBB-on-a-chip model achieved significant barrier integrity as evident by continuous tight junction formation and in vivo-like values of trans-endothelial electrical resistance (TEER). The TEER levels peaked above 4000 Ω · cm2 on day 3 on chip and were sustained above 2000 Ω · cm2 up to 10 days, which are the highest sustained TEER values reported in a microfluidic model. We evaluated the capacity of our microfluidic BBB model to be used for drug permeability studies using large molecules (FITC-dextrans) and model drugs (caffeine, cimetidine, and doxorubicin). Our analyses demonstrated that the permeability coefficients measured using our model were comparable to in vivo values. Our BBB-on-a-chip model closely mimics physiological BBB barrier functions and will be a valuable tool for screening of drug candidates. The residence time-based design of a microfluidic platform will enable integration with other organ modules to simulate multi-organ interactions on drug response. Biotechnol. Bioeng. 2017;114: 184-194. © 2016 Wiley Periodicals, Inc.

Advances in BBB on Chip and Application for Studying Reversible Opening of Blood–Brain Barrier by Sonoporation

Blood-brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research

Microfluidic organ-on-chip technology for blood-brain barrier research

Blood brain barrier-on-a-chip permeation to model neurological diseases using microfluidic biosensors

Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases

Functional Blood-Brain Barrier Model with Tight Connected Minitissue by Liquid Substrates Culture.

Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain

<i>In Situ</i> Surface Modification of Microfluidic Blood-Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles

In Situ Surface Modification of Microfluidic Blood-Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles

Recent Progress in Microfluidic Models of the Blood-Brain Barrier

Open Source Board Based Acoustofluidic Transwells for Reversible Disruption of the Blood–brain Barrier for Therapeutic Delivery

Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening

Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics

The blood–brain barrier: structure, regulation, and drug delivery

Development of a Blood-Brain Barrier Model in a Membrane-Based Microchip for Characterization of Drug Permeability and Cytotoxicity for Drug Screening

Constant-rate perfused array chip for high-throughput screening of drug permeability through brain endothelium

Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms

Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport

Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models